Human heat labile opsonins: evidence for their mediation via the alternate pathway of complement activation.
about
Opsonic activity in human serum chelated with ethylene glycoltetra-acetic acidInfluence of serum concentration on opsonization by the classical and alternative complement pathways.Opsonization of four Bacteroides species: role of the classical complement pathway and immunoglobulinHumoral bactericidal systems: nonspecific and specific mechanisms.Quantitation of the third component of human complement attached to the surface of opsonized bacteria: opsonin-deficient sera and phagocytosis-resistant strains.Opsonic requirements for phagocytosis of Streptococcus pneumoniae types VI, XVIII, XXIII, and XXVK-1 antigen of Escherichia coli: epidemiology and serum sensitivity of pathogenic strains.Serum heat-labile opsonins in systemic lupus erythematosusEvidence for quantitative variability of bacterial opsonic requirementsComplete absence of the third component of complement in man.Escherichia coli bacteremia in the squirrel monkey. I. Effect of cobra venom factor treatmentOpsonin system of the group B streptococcus.Human deficiency of the eighth component of complement. The requirement of C8 for serum Neisseria gonorrhoeae bactericidal activity.Serum-dependent phagocytosis of paraffin oil emulsified with bacterial lipopolysaccharide.Cooperative complement- and bacterial lectin-initiated bactericidal activity of polymorphonuclear leukocytes.Serum opsonic deficiency produced by Streptococcus pneumoniae and by capsular polysaccharide antigensInfluence of the Escherichia coli capsule on complement fixation and on phagocytosis and killing by human phagocytesInfluence of a deficiency of the second component of complement on the bactericidal activity of neutrophils in vitro.Absence of the eighth component of complement in association with systemic lupus erythematosus-like disease.Human erythrocytes bind and inactivate type 5 adenovirus by presenting Coxsackie virus-adenovirus receptor and complement receptor 1.Pneumococcal type-associated variability in alternate complement pathway activation.Phagocytosis. Clinical disorders of recognition and ingestion.Staphylococcus aureus opsonization mediated via the classical and alternative complement pathways. A kinetic study using MgEGTA chelated serum and human sera deficient in IgG and complement factors C1s and C2.The opsonic fragment of the third component of human complement (C3).The key role of peptidoglycan in the opsonization of Staphylococcus aureus.Role of Escherichia coli K capsular antigens during complement activation, C3 fixation, and opsonization.Requirements of immunoglobulin and the classical and alternative complement pathways for phagocytosis and intracellular killing of multiple strains of Gram-negative aerobic bacilliInfluence of the alternate complement pathway in opsonization of several bacterial species.Comparison of the in vitro bactericidal activity of human serum and leukocytes against bacteroides fragilis and Fusobacterium mortiferum in aerobic and anaerobic environments.Tetracyclines and host-defense mechanisms.Opsonisation and phagocytosis of group B meningococci by polymorphonuclear leucocytes: comparison of sulphonamide sensitive and resistant strainsSerum factors responsible for killing of Shigella.
P2860
Q28363587-480A2596-BBBC-46D5-BBF8-900918A44B41Q33899988-E6714B25-CFD4-4424-A792-E181D7F77681Q33900338-5CD6C0CB-AD05-4B8E-8530-CA40C2FB5A92Q34076763-CB573CE8-3E46-4B5A-BA97-D69B4A6D274DQ34099154-ECAB0FE4-2E66-4533-BE06-A0E4CEE4ABB2Q34417746-3C3AD671-D445-48EB-B534-1216DFD5B4A0Q34458146-299E8A5A-5414-43F6-AABA-2087C9CD1D2FQ34460894-C8FC1829-1489-4923-B4BB-BD9ABF99529BQ34464286-5388E115-E2EF-44AD-9A6B-19B91DFDC3DBQ34481903-343979B8-1DFE-4516-A702-1CFEC363D04BQ34499196-9C1D8912-CEBE-4565-847C-94023BA0F96FQ34506335-4F4F1F38-8A39-4071-80F6-AACBA25096D5Q35197032-BDC3DEBF-3D7F-44E8-9BB5-29304C86DCAFQ36272438-7EC814F9-8337-4372-8E92-5B8EE05D31B9Q36959461-6CD2033C-D1B8-4036-9D52-6CDEE07BCDC5Q36998931-277FDEA1-73F4-4AC2-B834-FA0EEB9A630CQ37019180-9FE4AB96-54B6-426E-A067-95D3925ED9C5Q37044212-78DE9325-A81D-40CA-961B-CF073733229EQ37046896-7D9CC343-B762-49FA-A063-8EBB9E1D6C9FQ37116929-6101A760-99C5-4593-8878-72E40C9B6253Q39063946-834D5CE1-98B7-4822-B900-58E17D0A752FQ39657436-9B007DBD-9011-4CCE-BB54-884ACF75FD16Q39660258-36D6271D-4833-46B7-8D05-7DCA60D402DEQ40317490-D9C505A9-C99B-4844-B3FD-25BCDFE1177AQ40692014-DD61679D-F9BF-4033-8499-80E03C1D24EBQ40877772-72E63539-C893-40B1-AED2-FE88A65E1A14Q40878195-90B9E2E6-F568-4EDD-92F9-71231EA81167Q40880032-792043D2-AED3-4B11-B6BE-71555FA33DA2Q40906562-D192A95D-2E73-47C3-A942-4A48ECE9B501Q41029437-4DFEAEF7-9114-4C25-B292-EA0A4DC8D40AQ42840587-8F403B7B-E3EA-4537-8902-A2AAF60B2C9DQ47847980-8C996875-9B62-454F-8F9C-5F79D5D8C425
P2860
Human heat labile opsonins: evidence for their mediation via the alternate pathway of complement activation.
description
1972 nî lūn-bûn
@nan
1972年の論文
@ja
1972年学术文章
@wuu
1972年学术文章
@zh-cn
1972年学术文章
@zh-hans
1972年学术文章
@zh-my
1972年学术文章
@zh-sg
1972年學術文章
@yue
1972年學術文章
@zh
1972年學術文章
@zh-hant
name
Human heat labile opsonins: ev ...... hway of complement activation.
@en
Human heat labile opsonins: ev ...... hway of complement activation.
@nl
type
label
Human heat labile opsonins: ev ...... hway of complement activation.
@en
Human heat labile opsonins: ev ...... hway of complement activation.
@nl
prefLabel
Human heat labile opsonins: ev ...... hway of complement activation.
@en
Human heat labile opsonins: ev ...... hway of complement activation.
@nl
P1476
Human heat labile opsonins: ev ...... hway of complement activation.
@en
P2093
P407
P577
1972-07-01T00:00:00Z